Mesoblast - 48 Year Dividend Yield History | MESO

Historical dividend payout and yield for Mesoblast (MESO) since 1971. The current TTM dividend payout for Mesoblast (MESO) as of February 15, 2019 is $0.00. The current dividend yield for Mesoblast as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.398B $0.017B
Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast's allogeneic, 'off-the-shelf' cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.167B 12.95
Gilead Sciences (GILD) United States $85.858B 10.77
Bio-Techne Corp (TECH) United States $7.121B 47.98